0001415889-22-012324.txt : 20221209 0001415889-22-012324.hdr.sgml : 20221209 20221209163305 ACCESSION NUMBER: 0001415889-22-012324 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20221207 FILED AS OF DATE: 20221209 DATE AS OF CHANGE: 20221209 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Javitt Jonathan C CENTRAL INDEX KEY: 0001303782 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38302 FILM NUMBER: 221455268 MAIL ADDRESS: STREET 1: 1201 NORTH MARKET STREET STREET 2: SUITE 111 CITY: WILMINGTON STATE: DE ZIP: 19801 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NRX Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001719406 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 822844431 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1201 ORANGE STREET STREET 2: SUITE 600 CITY: WILMINGTON STATE: DE ZIP: 19801 BUSINESS PHONE: 484-254-6134 MAIL ADDRESS: STREET 1: 1201 ORANGE STREET STREET 2: SUITE 600 CITY: WILMINGTON STATE: DE ZIP: 19801 FORMER COMPANY: FORMER CONFORMED NAME: Big Rock Partners Acquisition Corp. DATE OF NAME CHANGE: 20171012 4 1 form4-12092022_091256.xml X0306 4 2022-12-07 0001719406 NRX Pharmaceuticals, Inc. NRXP 0001303782 Javitt Jonathan C C/O NRX PHARMACEUTICALS, INC. 1201 NORTH MARKET STREET, SUITE 111 WILMINGTON DE 19801 true false true false Common Stock, par value $0.001 per share 2022-12-07 4 S 0 400000 1 D 12899997 I By Trust Common Stock, par value $0.001 per share 1422000 I By Trust Common Stock, par value $0.001 per share 146332 D Private sale pursuant to an option granted by the Reporting Person in 2017 in support of a financing for NeuroRx, Inc. Purchaser has agreed to hold the shares for a period of one year. Held by the Jonathan Javitt Living Trust. The Reporting Person is a trustee of the Trust. Held by the Javitt 2012 Irrevocable Dynasty Trust. The Reporting Person is the grantor of the Trust. /s/ Jonathan C. Javitt 2022-12-09